Last year, obesity treatment drug sales surpassed the immune anticancer drug ‘Kitruda,’ which had long held the top sales ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it has submitted a Biologics ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Seongnam, South Korea Saturday, December 27, 2025, 17:00 Hrs [IST] ...

Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 ...

Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...

A mother-of-two was diagnosed with lobular breast cancer after feeling a sharp pain in her breast during a hot yoga session.

Dr Dana Chase recalls early-career experiences and describes how revolutionary advances in surgery and personalized medicine ...

Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma industry by market cap. | Two investigational cardiometabolic drugs from Eli ...

Driven by a paradigm shift to curative early-stage interventions and surging ADC demand, the market offers massive upside.

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...